| Overview |
| bs-10610R-Cy3 |
| Dopamine Receptor D1 Antibody , Cy3 Conjugated |
| WB, FCM, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human, Rat |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Dopamine Receptor D1 |
| 11-100/446 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 1812 |
| P21728 |
| Cytoplasm, Cell membrane |
| DADR; DRD1A; D(1A) dopamine receptor; Dopamine D1 receptor; DRD1 |
| Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase. |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz